BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Massaro A, Giugliano RP, Norrving B, Oto A, Veltkamp R. Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants. International Journal of Stroke 2016;11:950-67. [DOI: 10.1177/1747493016660106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Levy P, Smadja D, Dorey J, Toumi M, Meinecke AK, Bowrin K, Briere JB. Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective. J Mark Access Health Policy 2019;7:1564506. [PMID: 30788086 DOI: 10.1080/20016689.2018.1564506] [Reference Citation Analysis]
2 Lip GY, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L. Antithrombotic Therapy for Atrial Fibrillation. Chest 2018;154:1121-201. [DOI: 10.1016/j.chest.2018.07.040] [Cited by in Crossref: 397] [Cited by in F6Publishing: 344] [Article Influence: 99.3] [Reference Citation Analysis]